Gero is a data-driven longevity company that leverages unique physics-based approach to aging turned into cutting-edge modeling platform for targets and biomarkers identification. Having a pipeline of longevity therapeutics in development, we also provide health and mortality risk assessment models for insurance and healthcare industries.
Longeveron is a leading regenerative medicine company focused on treating aging-related conditions, including Aging Frailty and Alzheimer’s disease, and also engages in contract manufacturing. Longeveron is staffed by a diverse team of professionals with expertise in cellular therapies and biotechnology. To date, Longeveron has received over $7 Million in research grants for its clinical trials and R&D programs from the National Institute of Aging, TEDCO, and the Alzheimer’s Association.